Concise review: using fat to fight disease: a systematic review of nonhomologous adipose-derived stromal/stem cell therapies

ME Bateman, AL Strong, JM Gimble, BA Bunnell - Stem Cells, 2018 - academic.oup.com
The objective of this Review is to describe the safety and efficacy of adipose stem/stromal
cells (ASC) and stromal vascular fraction (SVF) in treating common diseases and the next …

Stem/stromal cells for treatment of kidney injuries with focus on preclinical models

A Torres Crigna, C Daniele, C Gamez… - Frontiers in …, 2018 - frontiersin.org
Within the last years, the use of stem cells (embryonic, induced pluripotent stem cells, or
hematopoietic stem cells), Progenitor cells (eg, endothelial progenitor cells), and most …

Recent updates on mesenchymal stem cell based therapy for acute renal failure

A Missoum - Current urology, 2020 - karger.com
Acute kidney injury, formerly known as acute renal failure, is a pathological condition in
which ischemia or toxic damage contributes to the loss of renal proximal tubule epithelial …

[HTML][HTML] Urine-derived stem/progenitor cells: a focus on their characterization and potential

P Burdeyron, S Giraud, T Hauet… - World journal of stem …, 2020 - ncbi.nlm.nih.gov
Cell therapy, ie., the use of cells to repair an affected tissue or organ, is at the forefront of
regenerative and personalized medicine. Among the multiple cell types that have been used …

Adipose‐derived mesenchymal stem cells therapy for acute kidney injury induced by ischemia‐reperfusion in a rat model

JB Zhang, XQ Wang, GL Lu… - Clinical and …, 2017 - Wiley Online Library
Acute kidney injury (AKI) represents a group of complicated syndromes with a high mortality
rate. The administration of adipose‐derived mesenchymal stem cells (ADMSC s) has been …

Exploring the chondroitin sulfate nanogel's potential in combating nephrotoxicity induced by cisplatin and doxorubicin—An in-vivo study on rats

NF Alqahtani, MY Alfaifi, AA Shati, SEI Elbehairi… - International Journal of …, 2024 - Elsevier
In this study, we aim to unveil the potential of itaconyl chondroitin sulfate nanogel (ICSNG) in
tackling chronic kidney diseases triggered by the administration of CDDP and doxorubicin …

Regression modeling of the antioxidant-to-nephroprotective relation shows the pivotal role of oxidative stress in cisplatin nephrotoxicity

AG Casanova, M Harvat, L Vicente-Vicente… - Antioxidants, 2021 - mdpi.com
The clinical utility of the chemotherapeutic drug cisplatin is significantly limited by its
nephrotoxicity, which is characterized by electrolytic disorders, glomerular filtration rate …

Can mobilization of bone marrow stem cells be an alternative regenerative therapy to stem cell injection in a rat model of chronic kidney disease?

S Morsy, MF Mansour, M Abdo… - Physiological …, 2022 - Wiley Online Library
Chronic kidney disease (CKD) is a priority health problem affecting 36% of Egyptians.
Adipose‐derived mesenchymal stem cells (ADMSCs) have multidifferentiation capacity and …

[HTML][HTML] Impact of preconditioning stem cells with all-trans retinoic acid signaling pathway on cisplatin-induced nephrotoxicity by down-regulation of TGFβ1, IL-6, and …

M Khedr, N Barakat, IM El-Deen, F Zahran - Saudi Journal of Biological …, 2022 - Elsevier
The survival reduction after transplantation limited the clinical uses of stem cells so the
current study explored preconditioning adipose-derived stem cells (ADMSCs) and all-trans …

Bone marrow mesenchymal stem cells inhibit ferroptosis via regulating the Nrf2-keap1/p53 pathway to ameliorate chronic kidney disease injury in the rats

L Shao, Q Fang, C Shi, Y Zhang, C Xia… - Journal of Receptors …, 2023 - Taylor & Francis
Purpose Although bone marrow mesenchymal stem cells (BMMSCs) have been reported to
exhibit a protective effect on animal models of chronic kidney disease (CKD), the exact …